Tumor necrosis factor and clinical and metabolic courses after cardiac surgery in children

被引:6
作者
Sason-Ton, Y
Ben Abraham, R
Lotan, D
Dagan, O
Prince, T
Barzilay, Z
Paret, G [1 ]
机构
[1] Chaim Sheba Med Ctr, Dept Pediat Intens Care, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Gen Intens Care Unit, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1067/mtc.2002.124391
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study was undertaken to determine the relationship between plasma tumor necrosis factor concentrations and hemodynamic and metabolic parameters during the postoperative clinical course in children undergoing cardiac surgery. Methods: Tumor necrosis factor levels of 10 consecutive children undergoing surgery for repair of congenital heart defects were analyzed in blood samples drawn at predetermined time points during surgery and up to 24 hours thereafter. Clinical data were collected at these times for correlation to tumor necrosis factor levels. Results: All the patients survived. Tumor necrosis factor was detected in all 10 children. Tumor necrosis factor levels declined after induction of general anesthesia (201 +/- 65 pg/mL) steadily decreasing during surgery, reaching 80 +/- 50 pg/mL at 24 hours after the operation. Tumor necrosis factor levels were found to be inversely correlated with mean blood pressure values and indicators of acidosis (bicarbonate levels and base excess, P < .03). They were not correlated with the durations of cardiopulmonary bypass and aortic crossclamping. Conclusions: Tumor necrosis factor released into the circulation during and after pediatric cardiac surgery under cardiopulmonary bypass may be related to the hemodynamic and acid-base changes observed after cardiac surgery. Elucidation of the relationship between tumor necrosis factor and patient outcome in high-risk patients awaits further studies.
引用
收藏
页码:991 / 998
页数:8
相关论文
共 43 条
[31]  
OudemansvanStraaten HM, 1996, INTENS CARE MED, V22, P294
[32]   Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations [J].
Pilz, G ;
Fraunberger, P ;
Appel, R ;
Kreuzer, E ;
Werdan, K ;
Walli, A ;
Seidel, D .
CRITICAL CARE MEDICINE, 1996, 24 (04) :596-600
[33]   COMPLEMENT ACTIVATION AND RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-2, INTERLEUKIN-6 AND SOLUBLE TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-2 RECEPTORS DURING AND AFTER CARDIOPULMONARY BYPASS IN CHILDREN [J].
SAATVEDT, K ;
LINDBERG, H ;
GEIRAN, OR ;
MICHELSEN, S ;
AASEN, AO ;
PEDERSEN, T ;
MOLLNES, TE .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (01) :79-86
[34]   CYTOKINE AND COMPLEMENT LEVELS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS [J].
STEINBERG, JB ;
KAPELANSKI, DP ;
OLSON, JD ;
WEILER, JM .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (06) :1008-1016
[35]  
Strieter R.M., 1993, CRIT CARE MED, V21, P447
[36]   CYTOKINES .2. CYTOKINES AND LUNG INFLAMMATION - MECHANISMS OF NEUTROPHIL RECRUITMENT TO THE LUNG [J].
STRIETER, RM ;
LUKACS, NW ;
STANDIFORD, TJ ;
KUNKEL, SL .
THORAX, 1993, 48 (07) :765-769
[37]   Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men [J].
Tabardel, Y ;
Duchateau, J ;
Schmartz, D ;
Marecaux, G ;
Shahla, M ;
Barvais, L ;
Leclerc, JL ;
Vincent, JL .
SURGERY, 1996, 119 (01) :76-80
[38]   STEROID INHIBITION OF CYTOKINE-MEDIATED VASODILATION AFTER WARM HEART-SURGERY [J].
TEOH, KHT ;
BRADLEY, CA ;
GAULDIE, J ;
BURROWS, H .
CIRCULATION, 1995, 92 (09) :347-353
[39]  
TRACEY KJ, 1993, CRITICAL CARE MED, V21, P415
[40]   Tumor necrosis factor monoclonal antibody prevents alterations in leukocyte populations during cardiopulmonary bypass [J].
Vertrees, R.A. ;
Tao, W. ;
Kramer, G.C. ;
Nutt, L. ;
McDaniel, L.B. ;
DeVine, S.D. ;
Jesmok, G. ;
Zwischenberger, J.B. .
ASAIO Journal, 1994, 40 (03)